About the Authors

Beatriz Vera

Affiliations Navarra’s Health Research Institute (IDISNA) Pamplona, Spain, Program in Solid Tumors and Biomarkers, Foundation for the Applied Medical Research, Pamplona, Spain, Dpt of Medical Oncology, University Hospital of Navarra, Pamplona 31008, Spain

Naiara Martínez-Vélez

Affiliations Navarra’s Health Research Institute (IDISNA) Pamplona, Spain, Program in Solid Tumors and Biomarkers, Foundation for the Applied Medical Research, Pamplona, Spain, Dpt of Medical Oncology, University Hospital of Navarra, Pamplona 31008, Spain

Enric Xipell

Affiliations Navarra’s Health Research Institute (IDISNA) Pamplona, Spain, Program in Solid Tumors and Biomarkers, Foundation for the Applied Medical Research, Pamplona, Spain, Dpt of Medical Oncology, University Hospital of Navarra, Pamplona 31008, Spain

Arlet Acanda de la Rocha

Affiliations Navarra’s Health Research Institute (IDISNA) Pamplona, Spain, Program in Solid Tumors and Biomarkers, Foundation for the Applied Medical Research, Pamplona, Spain, Dpt of Medical Oncology, University Hospital of Navarra, Pamplona 31008, Spain

Ana Patiño-García

Affiliations Navarra’s Health Research Institute (IDISNA) Pamplona, Spain, Dpt of Pediatrics, University Hospital of Navarra, Pamplona 31008, Spain

Javier Saez-Castresana

Affiliations Navarra’s Health Research Institute (IDISNA) Pamplona, Spain, Brain Tumor Biology Unit, University of Navarra School of Sciences, 31008 Pamplona, Spain

Marisol Gonzalez-Huarriz

Affiliations Navarra’s Health Research Institute (IDISNA) Pamplona, Spain, Program in Solid Tumors and Biomarkers, Foundation for the Applied Medical Research, Pamplona, Spain, Dpt of Medical Oncology, University Hospital of Navarra, Pamplona 31008, Spain

Manel Cascallo

Affiliation VCN Biosciences, Sant Cugat del Vallés, 08174 Barcelona, Spain

Ramón Alemany

Affiliation Translational Research Laboratory, IDIBELL-Institut Catalá d’Oncologia, L’Hospitalet de Llobregat, 08907 Barcelona, Spain

Marta M. Alonso

mmalonso@unav.es

Affiliations Navarra’s Health Research Institute (IDISNA) Pamplona, Spain, Program in Solid Tumors and Biomarkers, Foundation for the Applied Medical Research, Pamplona, Spain, Dpt of Medical Oncology, University Hospital of Navarra, Pamplona 31008, Spain

Competing Interests

MC and RA are shareholders of VCN Biosciences. JSC and MMA are PLOS ONE Editors. There are no other competing interests. There are no patents, products in development or marketed products to declare. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: BV MMA APG. Performed the experiments: BV EX NMV AAR MGH. Analyzed the data: BV EX NMV APG JSC MMA. Contributed reagents/materials/analysis tools: RA MC. Wrote the paper: BV MMA.